genomewide characterization of host-pathogen interactions by ...
genomewide characterization of host-pathogen interactions by ...
genomewide characterization of host-pathogen interactions by ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
cfu / S9 cell<br />
cfu / S9 cell<br />
% PI-negative S9 cells<br />
Maren Depke<br />
Results<br />
HOST CELL GENE EXPRESSION PATTERN IN AN<br />
IN VITRO INFECTION MODEL<br />
Staphylococcal cfu per <strong>host</strong> cell after internalization and <strong>host</strong> cell vitality [Melanie Gutjahr,<br />
Petra Hildebrandt]<br />
After 2.5 h, an averaged number <strong>of</strong> 1.3 staphylococcal colony forming units (cfu)/ S9 cell were<br />
found in internalization experiments (data courtesy <strong>of</strong> Melanie Gutjahr). Although not statistically<br />
significant in the four biological replicates used for this study, a trend <strong>of</strong> increasing cfu / S9 cell<br />
along with increasing infection time was discernible and led to an internalization mean value <strong>of</strong><br />
2.3 cfu / S9 cell 6.5 h after start <strong>of</strong> infection (Fig. R.4.1 A).<br />
A<br />
S9 infection proteome and transcriptome<br />
4<br />
3<br />
2<br />
1<br />
B<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
RN1HG GFP RN1HG GFP<br />
infected S9 cells infected S9 cells<br />
2.5 h after start 6.5 h after start<br />
<strong>of</strong> time infection after start <strong>of</strong> infection <strong>of</strong> infection<br />
2.5 h<br />
6.5 h<br />
00<br />
untreated<br />
control<br />
1 2non-sorted3 4 5 sorted 6 7<br />
infected non-infected (GFP – ) infected (GFP + )<br />
2.5 h 6.5 h 2.5 h 6.5 h 2.5 h 6.5 h<br />
S9 cell samples<br />
Fig. R.4.1: Staphylococcal cfu per <strong>host</strong> cell after internalization and <strong>host</strong> cell vitality.<br />
A. Staphylococcal viable cell counts per S9 cell in infection experiments. The line indicates mean values per each analyzed time point.<br />
B. Percentages <strong>of</strong> viable PI – S9 cells in untreated control and after infection with S. aureus RN1HG GFP determined <strong>by</strong> FACS counting.<br />
Infected samples were analyzed for the two time points in different populations: without sorting or after sorting separately for GFP –<br />
and GFP + S9 cells. Mean values <strong>of</strong> n = 2 experiments.<br />
Cfu-data: courtesy <strong>of</strong> Melanie Gutjahr. FACS-data: courtesy <strong>of</strong> Petra Hildebrandt.<br />
Host cell vitality was determined <strong>by</strong> propidium iodide (PI) staining and counting in FACS<br />
(n = 2). Although 7.0 % and 12.1 % <strong>of</strong> cells in the infected, but non-sorted cell suspension were<br />
positive for PI and therefore not viable 2.5 h and 6.5 h after infection, respectively, compared to<br />
3.6 % <strong>of</strong> PI-positive dead cells in the untreated control, most <strong>of</strong> the dead, infected cells were<br />
discarded during the sorting procedure (Fig. R.4.1 B). Thus, cell vitality was not influenced in the<br />
subsets <strong>of</strong> sorted cells 2.5 h after infection (98.7 % in GFP + S9 cells, 99.0 % in GFP – S9 cells). After<br />
6.5 h, a minor drop in viability was recorded for the infected samples (97.3 % in GFP + S9 cells,<br />
98.8 % in GFP – S9 cells; data courtesy <strong>of</strong> Petra Hildebrandt).<br />
Reproducibility <strong>of</strong> replicates and clustering <strong>of</strong> treatment group members<br />
Staphylococcus aureus RN1HG GFP was used to infect S9 cells, a human bronchial epithelial<br />
cell line. The study included samples <strong>of</strong> two treatments, infected green fluorescence-positive<br />
FACS-sorted S9 cells and control cells that were exposed to medium, and analyzed the two time<br />
points 2.5 h and 6.5 h after start <strong>of</strong> infection. Hierarchical clustering visualized the grouping <strong>of</strong><br />
the array data sets according to their similarity (Fig. R.4.2). Biological replicates <strong>of</strong> each treatment<br />
111